Home » Topics » Regulatory

Regulatory
RSS

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

No Comments

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

No Comments

Dimethaid receives approval for Pennsaid lotion in U.K.

Dec. 11, 2000

No Comments

Testosterone buccal tablet enters late-stage clinical testing

Dec. 11, 2000

No Comments

Cubist acquires rights to oral ceftriaxone

Dec. 4, 2000

No Comments

Ziprasidone pharmaceutical formulations with good solubility properties

Nov. 30, 2000

No Comments

FDA approves Lovenox for seventh indication

Nov. 22, 2000

No Comments

FDA approves Boehringer Ingelheim's Micardis HCT

Nov. 21, 2000

No Comments

New Tamiflu indication for prevention of influenza approved by FDA

Nov. 21, 2000

No Comments

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Nov. 20, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Myobloc is first FDA-approved treatment for cervical dystonia

FDA approves Protopic for the treatment of eczema

Dimethaid receives approval for Pennsaid lotion in U.K.

Testosterone buccal tablet enters late-stage clinical testing

Cubist acquires rights to oral ceftriaxone

Ziprasidone pharmaceutical formulations with good solubility properties

FDA approves Lovenox for seventh indication

FDA approves Boehringer Ingelheim's Micardis HCT

New Tamiflu indication for prevention of influenza approved by FDA

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Regulatory RSS

Regulatory
RSS